We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
-0.82%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.21B
AUM Growth
-$192M
Cap. Flow
-$144M
Cap. Flow %
-4.48%
Top 10 Hldgs %
13.26%
Holding
448
New
23
Increased
88
Reduced
173
Closed
20

Top Sells

Rank Stock Value
1
SAFM
Sanderson Farms Inc
SAFM
+$19.5M
2
ITT icon
ITT
ITT
+$19.5M
3
KNL
Knoll, Inc.
KNL
+$14.2M
4
SAIA icon
Saia
SAIA
+$9.6M
5
PPL
PPL Corp
PPL
+$7.37M

Sector Composition

Rank Sector Weight
1 Technology 19.2%
2 Financials 17.91%
3 Industrials 12.16%
4 Consumer Discretionary 11.94%
5 Healthcare 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
376
Castle Biosciences
CSTL
$979M
$941K 0.03%
14,146
CTLT
377
DELISTED
CATALENT, INC.
CTLT
$926K 0.03%
6,959
SMAR
378
DELISTED
Smartsheet Inc.
SMAR
$922K 0.03%
+13,396
New +$985K
COP icon
379
ConocoPhillips
COP
$141B
$917K 0.03%
13,529
-120,239
-90% -$6.94M
RNG icon
380
RingCentral
RNG
$5.28B
$893K 0.03%
4,103
BAX icon
381
Baxter International
BAX
$14.2B
$884K 0.03%
10,988
LHCG
382
DELISTED
LHC Group LLC
LHCG
$875K 0.03%
5,578
ALB icon
383
Albemarle
ALB
$15.5B
$817K 0.03%
+3,732
New +$797K
CNTY icon
384
Century Casinos
CNTY
$34M
$809K 0.03%
60,049
PWR icon
385
Quanta Services
PWR
$101B
$785K 0.02%
6,895
-52,844
-88% -$5.3M
DAR icon
386
Darling Ingredients
DAR
$9.44B
$767K 0.02%
10,671
BBIO icon
387
BridgeBio Pharma
BBIO
$16.5B
$763K 0.02%
16,276
TTI icon
388
TETRA Technologies
TTI
$1.26B
$756K 0.02%
242,238
LFCR icon
389
Lifecore Biomedical
LFCR
$190M
$749K 0.02%
81,233
-1,560
-2% -$17K
PHAT icon
390
Phathom Pharmaceuticals
PHAT
$692M
$725K 0.02%
22,589
ENPH icon
391
Enphase Energy
ENPH
$5.53B
$706K 0.02%
4,706
FATE icon
392
Fate Therapeutics
FATE
$326M
$706K 0.02%
11,915
IVV icon
393
iShares Core S&P 500 ETF
IVV
$904B
$696K 0.02%
1,616
AZTA icon
394
Azenta
AZTA
$1.48B
$683K 0.02%
+6,677
New +$598K
DXCM icon
395
DexCom
DXCM
$32B
$660K 0.02%
4,832
KURA icon
396
Kura Oncology
KURA
$850M
$653K 0.02%
34,840
NBIX icon
397
Neurocrine Biosciences
NBIX
$16.6B
$630K 0.02%
6,572
-15,271
-70% -$1.44M
NMTR
398
DELISTED
9 Meters Biopharma
NMTR
$619K 0.02%
23,792
ARGX icon
399
argenx
ARGX
$54.1B
$586K 0.02%
1,939
SWKS icon
400
Skyworks Solutions
SWKS
$10.6B
$570K 0.02%
3,461

Similar funds

Chartwell Investment Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Chartwell Investment Partners held 448 positions worth $3.21B, down 5.6% from $3.4B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Chartwell Investment Partners withdrew a net $144M in Q3 2021, closing 20 positions and reducing 173 holdings. Its most notable exit was Knoll, Inc., an estimated $14.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Industrials.

Against the trend, Chartwell Investment Partners opened a new position in CTS Corp worth $10.9M.

  • Chartwell Investment Partners's largest Q3 2021 buy was CTS Corp: 353,042 shares worth $10.9M.
  • Chartwell Investment Partners added most to Hostess Brands, Inc. Class A Common Stock in Q3 2021, an estimated $16.3M increase.
  • Chartwell Investment Partners's biggest Q3 2021 reduction was Sanderson Farms Inc, cutting an estimated $19.5M.
  • Chartwell Investment Partners fully exited Knoll, Inc. in Q3 2021, selling an estimated $14.2M.
  • Chartwell Investment Partners's ten largest holdings make up 13% of its $3.21B portfolio in Q3 2021.
  • Chartwell Investment Partners opened 23 new positions and closed 20 in Q3 2021.
  • Chartwell Investment Partners's portfolio value fell 5.6% quarter-over-quarter to $3.21B.

Based on Chartwell Investment Partners's 13F filing for Q3 2021, filed 16 Nov 2021.